RecruitingNot ApplicableNCT05855421

Efficacy and Safety of Auricular Acupuncture in Depression During the Covid 19 Pandemic

Efficacy and Safety of Auricular Acupuncture in Depression During the Covid 19 Pandemic: a Multicenter Triple-blinded Randomized Clinical Trial

Sponsor

Universidade do Sul de Santa Catarina

Enrollment

280 participants

Start Date

Mar 1, 2023

Study Type

INTERVENTIONAL

Conditions

Quality of Life Insomnia Depression Anxiety Depressive Symptoms

Summary

Participants with moderate depressive symptoms measured by PHQ-9 will be randomized to receive auricular acupuncture. The triple blinded procedure will be conducted in 12 sessions (6 weeks). The primary outcome is the response to the treatment 3 months after inclusion.

Eligibility

Min Age: 18 YearsMax Age: 50 Years

Inclusion Criteria3

Age between 18 and 50 years old
PHQ-9 score between 10 and 19 (moderate depression)
Availability for sessions

Exclusion Criteria1

Use complementary and integrative practices at the last 3 months; Suicidal risk evaluated by question number 9 in the PHQ-9 Severe depression score in the PHQ-9 Prior use of auricular acupuncture Pregnancy Menopause Tape and metal allergy

Interventions

DEVICEAuricular Acupuncture

Aplication of semi-permanents needls in the ear by an experient and specialized professional using tradicional chinese maps and a specific device to find acupuncture points. There is a gap of one day minimum between sessions and two non-consecutive absences are allowed.